About Envera Health
Envera Health is a private company based in Gllen Allen, Virginia. It has reported $11,386,780 raised in six offerings on Form D since December 2015.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 15, 2022 | Feb 15, 2023 | $1,000,000fully sold | 4 | $250K | Debt, OptionsRule 506(b) | Form D ↗ |
| Jan 31, 2023 | Feb 15, 2023 | $1,000,000fully sold | 3 | $333K | Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 14, 2020 | Aug 20, 2020 | $1,000,000of $3.0M target | 3 | $333K | Debt, OptionsRule 506(b) | Form D ↗ |
| Jul 2, 2019 | Jul 15, 2019 | $2,386,780of $4.7M target | 4 | $596K | Equity, OptionsRule 506(b) | Form D ↗ |
| Apr 12, 2018 | Apr 26, 2018 | $2,000,000of $4.0M target | 4 | $500K | EquityRule 506(b) | Form D ↗ |
| Sep 10, 2015 | Dec 29, 2015 | $4,000,000fully sold | 5 | $800K | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $11,386,780 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Envera Health's Form D filed Feb 15, 2023.
Earlier filings also listed Suran Olyha (executive officer, last listed Aug 2020), Tammy Mullins (executive officer, last listed Jul 2019), Nancy Van Maren (executive officer, last listed Jul 2019), Erinne Dyer (executive officer, last listed Jul 2019), Johanna Epstein (executive officer, last listed Apr 2018), Daniel Neuwirth (ceo and director, last listed Apr 2018), Cheryl Michael (executive officer, last listed Apr 2018) and J. Mooney (director, last listed May 2016).